Tivity Health, Inc. TVTY
Set alert
32.50 +32.50 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.62B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 16.58
- Beta
- 2.14
- Short ratio
- 4.02
- Inst. own
- 95.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 3, 2022
- 50-d avg
- 32.15
- 200-d avg
- 27.77
- 1y target
- 27.00
Analyst view
Consensus: hold
Hold
Price target (mean) 27.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy4
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 5
- 2 months ago 5
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.46 | 0.46 – 0.46 | 0.48 | -4.2% | 135.08M | +12.5% | 1 |
| Next quarter | 0.46 | 0.46 – 0.46 | 0.42 | +9.5% | 138.92M | 0.0% | 1 |
| Current year | 1.75 | 1.75 – 1.75 | 1.60 | +9.4% | 541.18M | +12.5% | 1 |
| Next year | 1.96 | 1.94 – 1.98 | 1.75 | +12.0% | 616.14M | +13.9% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2022 | Credit Suisse | Maintained | — | Neutral |
| Jan 7, 2022 | Credit Suisse | Upgrade | Underperform | Neutral |
| Nov 9, 2021 | Credit Suisse | Maintained | — | Underperform |
| Feb 26, 2021 | Credit Suisse | Maintained | — | Underperform |
| Jan 15, 2021 | Credit Suisse | Downgrade | Neutral | Underperform |
| Nov 23, 2020 | Guggenheim | Upgrade | Neutral | Buy |
| Nov 17, 2020 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Oct 30, 2020 | Jefferies | Upgrade | Hold | Buy |
| Jun 12, 2020 | Guggenheim | Initiated | — | Neutral |
| May 21, 2020 | SunTrust Robinson Humphrey | Maintained | — | Hold |
| May 12, 2020 | SunTrust Robinson Humphrey | Maintained | — | Hold |
| Apr 13, 2020 | SunTrust Robinson Humphrey | Maintained | — | Hold |
| Feb 20, 2020 | Craig-Hallum | Downgrade | Buy | Hold |
| Feb 20, 2020 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Feb 20, 2020 | Jefferies | Downgrade | Buy | Hold |
| Feb 20, 2020 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jan 27, 2020 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jan 21, 2020 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jan 3, 2020 | Credit Suisse | Initiated | — | Neutral |
| Aug 23, 2019 | Chardan Capital | Maintained | — | Buy |
| Apr 11, 2019 | Craig-Hallum | Initiated | — | Buy |
| Dec 17, 2018 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jun 4, 2018 | Chardan Capital | Upgrade | Neutral | Buy |
| Feb 23, 2018 | Chardan Capital | Maintained | Neutral | Neutral |
| Nov 1, 2017 | Oppenheimer | Maintained | — | Outperform |
| Aug 29, 2017 | Chardan Capital | Initiated | — | Neutral |
| Mar 16, 2017 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Feb 7, 2017 | Cantor Fitzgerald | Initiated | — | Overweight |